Abstract
Eugenia uniflora, used ethnomedically in some tropical countries as an anti-infective, has shown anti-malarial and anti-trypanocidal activities. Therefore using bioactivity guided fractionation, anti-trichomonal activity of E. uniflora leaf was investigated. Anti-trichomonal activities of leaf methanol extract and its fractions against Trichomonas gallinae as well as their cytotoxicities using an in vitro haemaglutination assay were determined. Anti-trichomonacidal activities of the extract improved on purification up to a stage. Subfractions E2–5 had LC50 and LC90 values of 4.77 – 5.28, 18.49 – 25.00 and 4.53 – 5.18, 18.32 – 19.07 µg/ml at 24 and 48 hrs, respectively that were better than those of metronidazole. Further purification of E2–5 led to loss of activity suggesting that the active components were probably working synergistically and additively. Demonstration of low haemaglutination titre values of 0.00 – 5.33 by methanolic extract and its partition fractions suggested their low toxicity profile. The established safety of the leaf indicated that its anti-trichomonal activity was not due to non-specific cytotoxicity, hence could be used in ethnomedicine as an anti-trichomonal agent.
Keywords: Eugenia uniflora, leaf extract, Trichomonas gallinae, in vitro
Introduction
Trichomoniasis affects humans and animals causing heavy economic losses in poultry and livestock due to high mortality in birds, and morbidity in man (Adebajo et al., 2009). In Nigeria, the prevalence depends on age, profession and location of the citizens (Omisore et al., 2005). Its chemotherapy has been undermined by resistance, variable efficacy between strains or species, toxicity, need for parenteral administration and requirement for long courses of administration (Narcisi and Secor, 1996; Munoz et al., 1998; Camacho et al., 2000, 2003). Since the safe drugs available are limited, investigation of plants with possible anti-trichomonal activities is obligatory (Camacho et al., 2000, 2003; Adebajo et al., 2004, 2006, 2007, 2009; Omisore et al., 2005; Mahdi et al., 2006).
Eugenia uniflora L. (Myrtaceae), native to Surinam, Guyana, Southern Brazil, Uruguay, is widely distributed in other South American countries. It is cultivated as an ornamental hedge and for its edible fruits in tropical and subtropical countries, including Nigeria (Dalziel and Hutchinson, 1966; Adebajo et al., 1989a). Mono- and sesqui-terpenoids from leaf and fruit essential oils (Weyerstahl et al., 1988; Onayade et al., 1999); triterpenoids and their acetates (Rücker et al., 1977), tannins (Consolini and Sarubbio, 2002), macrocyclic hydrolysable tannin dimers (Lee et al., 1997), xanthine oxidase inhibitory flavonoids (Schmeda-Hirschmann et al., 1987) and uniflorines A and B (Matsumura et al., 2000) have been reported. Ethnomedically, various extracts of the whole plant or leaves are used in several countries as remedy for headaches, influenza, bronchitis, chest cold, cough, gout, sore throat, hypertension, hepatic disease, fever, rheumatism, stomach diseases and other gastro-intestinal disorders, as a diuretic, for its astringent and insect repelling properties, or drunk as a tea shortly before child birth (Weyerstahl et al., 1988; Adebajo et al., 1989a,b; Arai et al., 1999; Consolini and Sarubbio, 2002). It is also used to stimulate menstrual flow (Sussman, 1980), against obesity and diabetes (Arai et al., 1999); its volatile oil as a digestive, eupeptical and carminative remedy and in Nigeria, a hot water extract of the fresh leaf and unripe fruit is used as antipyretic, febrifuge and antimalarial drug (Adebajo et al., 1989a, b).
Anti-parasitic activities such as anti-trypanocidal and anti-malarial (Agbedahunsi and Aladesanmi, 1993; Adewunmi et al., 2001), other biological and pharmacological activities have been reported for the plant (Adebajo et al., 1989a; Schapoval et al., 1994; Gbolade et al., 1996; Arai et al., 1999; Matsumura et al., 2000; Consolini and Sarubbio, 2002). Anti-trichomonal activity of E. uniflora has not been reported. We therefore investigated the anti-trichomonal effects of methanolic leaf extract and fractions of E. uniflora, using activity-directed fractionation and Trichomonas gallinae.
Materials and methods
Plant material, extraction and purification
Eugenia uniflora leaves were collected in January 2005 from the shrubs earlier identified and voucher specimen FHI 102196 was deposited at the Forestry Research Institute of Nigeria, Ibadan, Nigeria (Adebajo et al., 1989a,b). A 5.0 kg of powdered leaf was cold extracted with 5 litres of methanol (MeOH) for 3 days, the extract was filtered and concentrated in-vacuo. This process was repeated four times and the combined extracts were further concentrated in vacuo to give a 541 g methanolic extract (A, 10.82 % w/w yield), which was subjected to anti-trichomonal activity testing.
TLC analyses of methanolic extract, its partition and chromatographic fractions
The Thin Layer Chromatographic (TLC) analyses of the extract (A) was done using the solvent systems: 1: n-hexane-CHCl3 1:1; 2: CHCl3 100%; 3: CHCl3-MeOH 9:1; 4: CHCl3-MeOH 7:3; 5: CHCl3-EtOAc-MeOH 5:2:3 and 6: CHCl3-MeOH-H2O 5:3:2 and the spots were detected by UV (366 nm) and 10 % H2SO4 followed by heating. Partition, vaccum liquid (VLC) and column chromatographic (CC) fractions were bulked into (B1–5), C1–5, D1–9, E1–13, F1–12, G1–7 and H1–7 based on similarity of their chromatograms and using solvent systems 1 – 6.
Partition fractions (B1–5)
520 g methanolic extract (A) was suspended in 150 ml water (H2O), solvent partitioned (5 × 250 ml) and concentrated in vacuo to give n-hexane (B1, 75 g), CHCl3 (B2, 133 g), EtOAc (B3, 65 g), BuOH (B4, 123.4 g) and aqueous (B5, 106 g) partition fractions that were tested for anti-trichomonal activity.
Vacuum liquid chromatographic (VLC) fractions C1–C5
The most active B2 and B3 fractions were combined (183 g) and subjected to VLC, gradiently eluted with petroleum ether, CHCl3, MeOH. The fractions, based on TLC similarities in solvent systems (1–3, 5), were bulked into C1 (petroleum ether 100 %, 5 × 200 ml, 32.0 g), C2 (pet. ether-CHCl3 1:1, 5 × 200 ml, 48.2 g) and C3 – C5.
VLC subfractions D1–9 and E1–13
Most active C1 and C2 were separately subjected to VLC. VLC of C1 (31.0 g) was repeated with a more gradient elution of petroleum ether, CHCl3, MeOH and similarly bulked to give D1 – D6, D7 (CHCl3 100 %, 450 ml, 1.6 g) and D8 – D9. A 40.9 g of C2 was similarly treated to obtain E1, E2 (pet. ether-CHCl3 45:55, 450 ml, 1.9 g), E3 (pet. ether-CHCl3 45:55, 600 ml, 2.3 g), E4 (pet. ether-CHCl3 45:55, 600 ml; pet. ether-CHCl3 30:70, 700 ml, 7.1 g), E5 (CHCl3 100 %, 900 ml, 2.7 g) and E6 – E13.
CC subfractions F1–12
The most active D7 and E2–5 showed great similar TLC characteristics and due to their low yields, they were combined and further purified using CC to obtain CC subfractions F1 – F12.
Anti-trichomonal bioassay
Trichomonas gallinae were collected from local Pigeon Columba lavia (Anth) Columbidea by inserting a sterile cotton swab into its crop (Narcisi and Secor, 1996; Omisore et al., 2005). The swab was dipped into a test tube of normal saline, distributed into test tubes of Ringers-egg-serum culture for enteric protozoan, prepared according to the modified method of Levine (1961) and incubated at 37°C for growth. Stock solutions of Metronidazole (positive control drug), the extract, fractions and subfractions obtained above, in DMSO at the concentration of 20 mg/ml were made. Their serial dilutions to 0.00, 3.906, 7.8125, 15.625, 31.25, 62.5, 125, 250, 500 and 1,000 µg/ml with the fluid nutrient solution were used as the test agents. A 50 µl of each test agent and 150 µl of the nutrient solution were pipetted into the 96-microwells and incubated in the steam incubator at 37°C for 24 and 48 hr; 50 µL of DMSO served as a negative control. The number of surviving trichomonads per millilitre in each well for 0, 24 and 48 hr were counted using the microscope. The experiments were replicated nine times (Adebajo et al., 2009). The lethal doses (LC50 and LC90) at these times were determined using the Microsoft Excel 2008 and subjected to statistical analysis using ANNOVA followed by Dunnett post-hoc test. P < 0.05 was considered as significant.
Cytotoxicity Assay
Cytotoxicity of the extract and its fractions were determined by haemagglutination activity using formaldehyde fixed bovine erythrocytes. 100 µL of phosphate buffer saline (PBS) was pipetted into 96-well microtitre plates. The first row was without the extract/fractions and used as control. The extract and fractions (100 µL) were added into the first well of the second row, and two-fold serial dilutions were made until the last well in row three. Thereafter, 50 µL of bovine red blood cell was added to all the wells and incubated for one hour. The presence of buttons at the centre of the well indicated no agglutination and the heamagglutination titre values of the extract/fractions were read as the reciprocal of the last dilution showing agglutination (Peumans, et al, 1982; Sadique et al., 1989; Wang et al, 1995).
Results
The anti-trichomonal activities of E. uniflora leaf methanolic extract (A), its five partition fractions (B1–5) and the VLC subfractions (C1–5) of the most active B2 and B3 fractions were given in Table 1. Those of the subfractions D1–9, E1–13 and F1–12 were presented in Tables 2 – 4, respectively. Haemagglutination values, as indices of cytotoxicities of the leaf extract and partition fractions, were also given in Table 5.
Table 1.
Anti-trichomonal activities of Eugenia uniflora leaf methanolic extract, its partition and VLC fractions.
| Extract/Fractions/Drug | 24 hrs | 48 hrs | ||
| LC50 (µg/ml) | LC90 (µg/ml) | LC50 (µg/ml) | LC90 (µg/ml) | |
| MeOH (A) | 61.70±1.65† | 386.84±4.32† | 55.15± 2.17† | 302.93±9.54† |
| n-Hexane (B1) | 40.00±2.24*,† | 271.10±5.72*,† | 70.52± 3.41† | 551.69±2.37*,† |
| CHCl3 (B2) | 27.60± 3.76* | 126.95±2.82*,† | 18.67± 3.29* | 68.82± 5.41* |
| EtOAc (B3) | 41.51± 4.48† | 194.79±7.57*,† | 24.18± 1.37* | 86.39±2.04* |
| BuOH (B4) | 58.62± 2.56† | 353.79±10.75† | 52.31±3.71† | 427.39±9.65*,† |
| Aqueous (B5) | 103.19±0.96*,† | 704.65±2.66*,† | 59.10± 8.34† | 592.06± 2.01*,† |
| C1 | 35.08±2.89* | 238.50± 9.17*,† | 18.05± 5.09* | 106.90± 5.21*,† |
| C2 | 36.43± 2.73*,† | 265.34± 9.43*,† | 32.69± 4.66*,† | 156.95± 5.68* |
| C3 | 222.83± 9.26* | 1063.57±5.81*,† | 40.88± 4.95† | 263.50± 4.76† |
| C4 | 75.10± 4.64*,† | 747.77± 3.14*,† | 206.08± 9.86* | 1010.40±10.56*,† |
| C5 | 125.69±1.30*,† | 1274.49±4.89*,† | 27.12± 7.00 | 168.75±11.11* |
| Metronidazole | 13.67± 0.87* | 42.86± 2.60* | 14.04± 5.85* | 61.37±8.69* |
A: Methanolic extract; B1: N-hexane, B2: Chloroform, B3: Ethylacetate, B4: Butanol, B5: Aqueous partition fractions; C1–5: VLC subfractions of the combined most active partition fractions B2 and B3. N = 9; p < 0.05; *: LC50 and LC90 vs MeOH, †: LC50 and LC90 vs metronidazole. LC50 and LC90: Values ± SEM.
Table 2.
Anti-trichomonal activities of subfractions D1–9.
| Subfractions / Drug | 24 hrs | 48 hrs | ||
| LC50 (µg/ml) | LC90 (µg/ml) | LC50 (µg/ml) | LC90 (µg/ml) | |
| C1 | 35.08±2.89† | 238.50± 9.17† | 32.69± 4.66† | 106.90± 5.21† |
| D1 | 34.91 ± 3.14† | 246.76±14.86† | 49.11± 1.98† | 218.26±13.16*,† |
| D2 | 61.99± 2.11*,† | 300.82± 16.88† | 39.90± 1.77† | 130.90±10.69† |
| D3 | 37.83± 1.54† | 188.24± 12.36*,† | 34.68±3.05*,† | 131.35±10.89† |
| D4 | 26.76± 0.99† | 204.09±13.25† | 56.23± 2.32† | 235.11±7.60*,† |
| D5 | 33.34± 1.46† | 149.20±17.74*,† | 44.82± 3.09† | 181.85± 7.36† |
| D6 | 25.95± 0.78† | 112.01±11.56*,† | 46.56±4.26† | 135.10± 5.33† |
| D7 | 13.81± 1.27* | 41.26± 8.10*,† | 12.38±4.34* | 37.71± 2.79*,† |
| D8 | 30.40± 3.30† | 127.47± 8.77*,† | 22.03± 0.30* | 72.21± 2.97* |
| D9 | 55.24±0.30*,† | 318.27±19.95*,† | 31.97±1.95† | 118.22±4.99† |
| Metronidazole | 13.67± 0.90* | 42.86± 0.87* | 14.04± 5.85* | 61.37±8.69* |
D1–9: VLC subfractions of an active VLC fraction C1. N = 9; p < 0.05; *: LC50 and LC90 vs C1; †: LC50 and LC90 vs metronidazole. LC50 and LC90: Values ± SEM.
Table 4.
Anti-trichomonal activities of subfractions F1–12.
| CC Subfractions | 24 hrs | 48 hrs | ||
| LC50 (µg/ml) | LC90 (µg/ml) | LC50 (µg/ml) | LC90 (µg/ml) | |
| D7 | 13.81± 1.27 | 41.26± 8.10 | 12.38±4.34 | 37.71± 2.79† |
| F1 | 100.21± 0.83*,† | 1347.09±5.14*,† | 179.59 ±1.04*,† | 4692.0 ± 6.19*,† |
| F2 | 26.63 ± 0.71*,† | 78.43 ± 8.83*,† | 23.56 ± 0.99*,† | 128.14±11.24*,† |
| F3 | 22.28 ± 0.64*,† | 91.00 ± 3.94*,† | 24.76 ± 0.72*,† | 96.63 ± 5.33*,† |
| F4 | 23.96 ± 0.70*,† | 117.04 ±4.18*,† | 19.46 ± 0.72*,† | 99.32 ±7.26*,† |
| F5 | 21.30 ± 1.09*,† | 97.23 ± 6.13*,† | 21.09 ± 0.52*,† | 98.49 ± 2.64*,† |
| F6 | 18.49 ± 0.89*,† | 69.85 ± 5.75*,† | 16.88 ± 0.35 | 64.71 ± 6.42* |
| F7 | 16.79 ± 0.92 | 60.60 ± 4.11 | 14.17 ± 0.95 | 63.59 ± 2.63* |
| F8 | 26.41 ± 0.59*,† | 138.84 ± 6.68*,† | 20.80 ± 0.73*,† | 104.57 ± 6.26*,† |
| F9 | 47.21 ± 0.83*,† | 203.96 ± 7.91*,† | 42.95 ± 0.78*,† | 432.16 ± 2.14*,† |
| F10 | 36.29 ± 1.02*,† | 177.24 ± 7.32*,† | 60.34 ± 0.70*,† | 571.35 ± 5.49*,† |
| F11 | 62.13 ± 0.70*,† | 382.18 ± 8.47*,† | 33.00 ± 0.62*,† | 198.15 ± 7.59*,† |
| F12 | 257.80 ±0.89*,† | 11960.92±8.12*,† | 137.74 ±1.07*,† | 2114.56±5.86*,† |
| Metronidazole | 13.67± 0.30 | 42.86 ± 0.87 | 14.04 ± 1.95 | 61.37 ± 8.69* |
F1–12: CC subfractions of the combined most active VLC fractions D7 and E2–5. N = 9; p < 0.05; *: LC50 and LC90 vs D7; †: LC50 and LC90 vs metronidazole. LC50 and LC90: Values ± SEM.
Table 5.
Agglutination and haemagglutination values of the leaf extract and partition fractions.
| Extract/fractions | Agglutination concentrations (mg/ml) |
Haemagglutination titre value |
| MeOH (A) | 0.26 ± 0.05 | 5.33 ± 2.93 |
| n-Hexane (B1) | 3.00 ± 0.00 | 0.33 ± 0.00 |
| CHCl3 (B2) | 0.23 ± 0.05 | 4.67 ± 0.67 |
| EtOAc (B3) | 0.28 ± 0.05 | 4.00 ± 0.77 |
| BuOH (B4) | 0.47 ± 0.09 | 2.34 ± 0.34 |
| Aqueous (B5) | 0.53 ± 0.02 | 1.89 ± 2.17 |
A: Methanol extract; B1: N-hexane, B2: Chloroform, B3: Ethylacetate, B4: Butanol, B5: Aqueous partition fractions. LC50 and LC90: Values ± SEM.
Discussion
Leaf methanolic extract of E. uniflora was less active than Metronidazole (Table 1). The CHCl3 and EtOAc partition fractions were the most active and had lower LC50 and LC90 values at 48 than 24 hrs indicating, that their activities were trichomonacidal. Hence, the main active constituents were likely to be moderately non-polar to mediumly polar in nature. N-hexane fraction had higher LC50 and LC90 values at 48 than 24 hrs, indicating that the trichomonads were able to recover after 24 hrs and the activity was trichomonastatic (Table 1). Similar anti-parasitic activities of antimalarial (Agbedahunsi and Aladesanmi, 1993) and anti-trypanocidal (Adewunmi et al., 2001) have been reported for the leaf extract and fractions. However, anti-trichomonal activity of the plant is hereby reported for the first time.
C1 and C2 with activities comparable to their mother fractions B2–3, were the most active VLC fractions obtained by purification of the combined fractions B2–3. They were however less active than metronidazole (Table 1) and since their TLC characteristics were slightly different, they were separately further purified. Subfractions D1, D3, D5 and D7 gave similar activity at 24 and 48 hr. Trichomonacidal activity of D7 was better than that of C1, showing that it should contain more of the active compounds (Tables 1, 2). D7 with LC50 values of 13.81 and 12.38 µg/ml at 24 and 48 hr, respectively was as potent as metronidazole (Table 2). Similarly, E2–E5 had higher activities and lower LC50 and LC90 values than C2 and metronidazole (Tables 1, 3).
Table 3.
Anti-trichomonal activities of subfractions E1–13.
| Subfractions/Drug | 24 hrs | 48 hrs | ||
| LC50 (µg/ml) | LC90 (µg/ml) | LC50 (µg/ml) | LC90 (µg/ml) | |
| C2 | 36.43± 2.73*,† | 265.34± 9.43† | 18.05± 5.09 | 156.95± 5.68† |
| E1 | 131.71 ± 1.38*,† | 2363.73 ± 9.33*,† | 133.37 ±2.04*,† | 2124.73 ±12.72*,† |
| E2 | 4.95 ± 0.78*,† | 20.93 ± 1.92* | 3.61 ± 2.54*,† | 18.69 ± 2.96*,† |
| E3 | 5.61± 1.30*,† | 20.72 ± 3.29* | 3.24 ± 0.63*,† | 16.28 ± 2.03*,† |
| E4 | 4.77 ± 0.83*,† | 18.49 ± 2.94* | 4.53 ± 1.23*,† | 18.38 ± 3.70*,† |
| E5 | 7.28 ± 0.87*,† | 25.00 ± 2.95* | 4.95 ± 0.81*,† | 19.07 ± 2.20*,† |
| E6 | 40.28 ± 0.85† | 168.04 ± 8.27*,† | 22.53 ± 1.38† | 157.95 ± 6.31† |
| E7 | 32.78 ± 1.28† | 182.67 ± 4.63*,† | 33.38 ± 0.85*,† | 207.89 ± 7.64† |
| E8 | 84.27 ± 0.75*,† | 935.05 ± 11.11*,† | 58.11± 0.99*,† | 565.03 ± 9.30*,† |
| E9 | 61.55 ± 0.93*,† | 828.32 ± 4.06*,† | 63.40 ± 0.66*,† | 551.64 ± 7.22*,† |
| E10 | 60.73 ± 0.79*,† | 694.85 ± 5.53*,† | 58.87 ± 1.45*,† | 390.53 ± 8.14*,† |
| E11 | 69.15 ± 0.09*,† | 725.31 ± 9.33*,† | 78.63 ± 0.64*,† | 639.83 ± 3.57*,† |
| E12 | 69.28 ± 1.22*,† | 507.34 ± 3.27*,† | 89.16 ± 0.44*,† | 680.21 ± 6.99*,† |
| E13 | 70.46 ± 0.37*,† | 735.55 ± 9.27*,† | 124.46 ± 0.87*,† | 959.10 ± 6.63*,† |
| Metronidazole | 13.67 ± 0.03* | 42.86 ± 0.87* | 14.04 ± 1.95 | 61.37 ± 8.69* |
E1–13: VLC subfractions of an active VLC fraction C2. N = 9; p < 0.05; *: LC50 and LC90 vs C2; †: LC50 and LC90 vs metronidazole. LC50 and LC90: Values ± SEM.
Up to this stage, purification led to better activities than the mother fractions, suggesting that chemical compounds in the extract are responsible for its anti-trichomocidal activity. Hence, the most active D7 and E2–E5 fractions were combined and subjected to CC. The resulting fractions F1–12 had higher LC50 and LC90 values than D7 and E2–E5 subfractions (Tables 2 – 4), indicating that further purification did not result in improved activity. Only F6 and F7 had activities that were comparable to that of metronidazole and D7 (Table 4).
The decreased activity as purification progressed showed that the active trichomocidal components of the leaf were probably working synergistically. Comparing the TLC characteristics of the various active fraction/subfractions showed that spots with Rf 0.12 and 0.06 (silica gel, 100% CHCl3) fluorescencing blue under UV and red colour with H2SO4 were common to all of them, suggesting that the active compounds are likely to be moderately polar. Since flavonoids and phenolics have been detected during phytochemical screening of the combined active B2 and B3 fractions of E. uniflora leaf (Adebajo et al., 1989a) and xanthine oxidase inhibitory flavonoids have been isolated from equivalent leaf fraction (Schmeda-Hirschmann et al., 1987), the active constituents are therefore suspected to be flavonoids. Due to this demonstrated synergism of the constituents of this plant, further purification was deemed unnecessary.
Metronidazole is the drug of choice in the treatment of human and animal trichomoniasis all over the world. Side effects of metronidazole include allergic reaction, nausea, diarrhoea, dryness of the mouth, leucopoenia and intolerance to alcohol. It is also not recommended during the first trimester of pregnancy or breast feeding while increasing resistance against metronidazole is common (Narcisi and Secor, 1996; Munoz et al., 1998). Acceptable drugs, particularly from plant sources, against trichomoniasis are therefore of a high priority (Adebajo et al., 2006, 2007; Mahdi et al., 2006). Hence, any of the purified fractions of D7, E2–5, F6 and F7 that were more active or comparable in activity to metronidazole, may be relevant as a readily available alternative drug for the treatment of animal and human trichomoniasis.
The MeOH extracts of Murrya koenigii leaf and stem were reported less active than metronidazole, and its carbazole constituents, especially girinimbine, girinimbilol and girinimbiyl acetate with comparable activity with metronidazole, were the active compounds (Adebajo et al., 2004, 2006). MeOH extracts of the furocoumarin-producing M. koenigii seeds and pericarp also showed comparable anti-trichomonal activities with metronidazole. Their active constituents were identified as the furocoumarins isoimperatorin, isogosferol and indicolatone. Since none of the furocoumarins isolated gave a significantly higher activity than the MeOH extracts of the seeds or pericarps, it has been suggested that active compounds were probably working synergistically (Adebajo et al 2007). Antitrichomal activities of extracts of Dorstenia barteri and D. convexa (Omisore et al., 2005) and Harungana madagascariensis have also been reported (Iwalewa et al., 2008). Imperatorin and 3-formylcarbazole that had better activities than the dichloromethane extract were the most active compounds of Clausena lansium stem bark (Adebajo et al., 2009).
The E. uniflora leaf extract and partition fractions showed low haemaglutination titre values (Table 5), suggesting their low toxicity profile and safe internal use in medicine (Sadique et al., 1989). Since the plant is therefore considered safe, its anti-trichomonal activity was not due to non-specific cytotoxicity. A hydro-alcoholic extract of the leaves, when administered orally to mice in doses up to 4,200 mg/kg, lacked acute or subacute toxicity. This extract also gave an LD50 of 220 mg/kg when given i.p. to mice. Based on these results, the plant was declared safe for internal use in treating gout by herbalists in Paraguay (Schmeda-Hirschmann et al., 1987). Our present results of no toxicity therefore agreed closely with the earlier report (Schmeda-Hirschmann et al., 1987).
Conclusion
Anti-trichomonal activity directed purification of E. uniflora leaf extract gave subfractions D7, E2–5, F6 and F7 with higher or comparable activity to that of metronidazole. Since the folkloric use of the plant as a safe anti-parasitic agent was confirmed, E. uniflora leaf could be used in ethnomedicine as an anti-trichomonal agent and its chemotherapeutic potential may need to be further exploited.
Acknowledgements
The authors are grateful to the Obafemi Awolowo University Research Committee, OAU, Ile-Ife, Nigeria for the research grant, 11-813-ACZ, for the study and to Mr. K.A. Olaniyan, DRPU, Ile-Ife.
References
- 1.Adebajo AC, Oloke KJ, Aladesanmi AJ. Antimicrobial activity of the leaf extract of Eugenia uniflora. Phytother Res. 1989a;3:258–259. [Google Scholar]
- 2.Adebajo AC, Oloke KJ, Aladesanmi AJ. Antimicrobial activity and microbial transformation of volatile oils of Eugenia uniflora. Fitoterapia. 1989b;60:451–455. [Google Scholar]
- 3.Adebajo AC, Olayiwola G, Verspohl EJ, Iwalewa EO, Omisore NOA, Bergenthal D, Kumar V, Adesina SK. Evaluation of the Ethnomedical claims of Murraya koenigii. Pharmaceut Biol. 2004;42:610–620. [Google Scholar]
- 4.Adebajo AC, Ayoola OF, Iwalewa EO, Akindahunsi AA, Omisore NOA, Adewunmi CO, Adenowo TK. Anti-trichomonal, biochemical and toxicological activities of methanolic extract and some carbazole alkaloids isolated from the leaves of Murraya koenigii growing in Nigeria. Phytomed. 2006;13:246–254. doi: 10.1016/j.phymed.2004.12.002. [DOI] [PubMed] [Google Scholar]
- 5.Adebajo AC, Olaniyan KA, Adewunmi CO. Anti-trichomonal activities of extract and furocoumarins of Murraya koenigii fruits. Ife J Sci. 2007;9:155–160. [Google Scholar]
- 6.Adebajo AC, Iwalewa EO, Obuotor EM, Ibikunle GF, Omisore NO, Adewunmi CO, Obaparusi OO, Klaes M, Adetogun GE, Schmidt TJ, Verspohl EJ. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: Anti-trichomonal, anti-diabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J Ethnopharmacol. 2009;122:10–19. doi: 10.1016/j.jep.2008.11.015. [DOI] [PubMed] [Google Scholar]
- 7.Adewumi CO, Agbedahunsi JM, Adebajo A C, Aladesanmi A J, Murphy N, Wando J. Ethno-veterinary medicine: Screening of Nigerian medicinal plants for trypanocidal properties. J Ethnopharmacol. 2001;77:19–24. doi: 10.1016/s0378-8741(01)00247-1. [DOI] [PubMed] [Google Scholar]
- 8.Agbedahunsi JM, Aladesanmi AJ. Effect of Eugenia uniflora on early malaria infection. Fitoterapia. 1993;64:174–175. [Google Scholar]
- 9.Arai I, Amagaya S, Komatsu Y, Okada M, Hayashi T, Kasai M, Arisawa M, Momose Y. Improving effects of the extracts from Eugenia uniflora on hyperglycemia and hypertriglyceridemia in mice. J Ethnopharmacol. 1999;68:307–314. doi: 10.1016/s0378-8741(99)00066-5. [DOI] [PubMed] [Google Scholar]
- 10.Camacho MDR, Phillipson JD, Croft S L. Natural products as sources of anti-protozoal drugs. Current Opinion in Anti-effective Investigational Drugs. 2000;2:47–628. [Google Scholar]
- 11.Camacho MDR, Phillipson JD, Croft S L, Soli PN, Marshall SJ, Ghazanfar SA. Screening of plant extracts for antiprotozoal and cytotoxic activities. J Ethnopharmacol. 2003;89:185–191. doi: 10.1016/s0378-8741(03)00269-1. [DOI] [PubMed] [Google Scholar]
- 12.Consolini AE, Sarubbio MG. Pharmacological effects of Eugenia uniflora (Myrtaceae) aqueous crude extract on rat's heart. J Ethnopharmacol. 2002;81:57–63. doi: 10.1016/s0378-8741(02)00039-9. [DOI] [PubMed] [Google Scholar]
- 13.Dalziel JM, Hutchinson J. Flora of West Tropical Africa. 3rd edition. London S.W.: The Crown Agents for the Overseas Governments and Administrations; 1966. pp. 235–242. Vol. 1 Part 1. [Google Scholar]
- 14.Gbolade AA, Ilesanmi OR, Aladesanmi AJ. The contractile effects of the extracts of Eugenia uniflora on isolated rat duodenum. Phytother Res. 1996;10:613–615. [Google Scholar]
- 15.Iwalewa EO, Omisore NO, Adewunmi CO, Gbolade AA, Ademowo OG, Nneji C, Agboola OI, Daniyan OM. Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria. J Ethnopharmacol. 2008;117:507–511. doi: 10.1016/j.jep.2008.02.019. [DOI] [PubMed] [Google Scholar]
- 16.Lee MH, Nishimoto S, Yang LL, Yen KY, Hatano T, Yoshida T, Okuda T. Two macrocyclic hydrolysable tannin dimmers from Eugenia uniflora. Phytochem. 1997;44:1343–1349. [Google Scholar]
- 17.Levine ND. Protozoan parasites of domestic animals and man. In: Levine ND, editor. Laboratory Diagnosis of Protozoan Infection. Minneapolis, USA: Burgess Publishing Company; 1961. pp. 377–393. [Google Scholar]
- 18.Mahdi NK, Gany ZH, Sharief M. Alternative drugs against Trichomonas vaginalis. Eastern Mediterranean Health J. 2006;12:679–684. [PubMed] [Google Scholar]
- 19.Matsumura T, Kasai M, Hayashi T, Arisawa M, Momose Y, Arai I, Amagaya S, Komatsu Y. α-Glucosidase inhibitors from Paraguayan medicine, Ñangapiry, the leaves of Eugenia uniflora. Pharmaceut Biol. 2000;38:302–307. doi: 10.1076/1388-0209(200009)3841-AFT302. [DOI] [PubMed] [Google Scholar]
- 20.Munoz E, Castella J, Gutierrez JF. In-vivo and in-vitro sensitivity of Trichomonas gallinae to some Nitroimidazole drugs. J Vet Parasitol. 1998;78:239–246. doi: 10.1016/s0304-4017(98)00164-2. [DOI] [PubMed] [Google Scholar]
- 21.Narcisi EM, Secor NE. In-vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicr Agents & Chemother. 1996;40:1121–1125. doi: 10.1128/aac.40.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Omisore NOA, Adewunmi CO, Iwalewa EO, Ngadjui BT, Adenowo TK, Abegaz BM, Watchueng J, Ojewole JAO. Anti-trichomonal and antioxidant activities of Dorstenia barteri and D. convexa. Braz J Med & Biol Res. 2005;38:1087–1094. doi: 10.1590/s0100-879x2005000700012. [DOI] [PubMed] [Google Scholar]
- 23.Onayade OA, Adebajo AC, Looman A. Effect of cold storage on the composition of the essential oils of Eugenia uniflora leaves. Nig J Nat Prod and Med. 1999;3:79–82. [Google Scholar]
- 24.Peumans NJ, Stinissen HM, Carlier AR. Lectin synthesis in developing and germinating wheat and rye embryos. Biochem J. 1982;156:41–44. doi: 10.1007/BF00393441. [DOI] [PubMed] [Google Scholar]
- 25.Rücker G, Assis Brasil E, Silva G, Bauer L, Schikarski M. Neue inhaltsstoffe aus Stenocalyx michelii. Planta Med. 1977;31:305–340. [Google Scholar]
- 26.Sadique J, Al-Rqobab NA, Bughaith MF, El-Gindy AR. The bioactivity of certain medicinal plants on the stabilization of RBC membrane system. Fitoterapia. 1989;60:525–532. [Google Scholar]
- 27.Schapoval EES, Silveira SM, Miranda ML, Alice CB, Henriques AT. Evaluation of some pharmacological activities of Eugenia uniflora L. J Ethnopharmacol. 1994;44:137–142. doi: 10.1016/0378-8741(94)01178-8. [DOI] [PubMed] [Google Scholar]
- 28.Schmeda-Hirschmann G, Theoduloza C, Francoa L, Ferro E, Rojas de Aria A. Preliminary pharmacological studies on Eugenia uniflora leaves: Xanthine oxidase inhibitory activity. J Ethnopharmacol. 1987;21:183–186. doi: 10.1016/0378-8741(87)90128-0. [DOI] [PubMed] [Google Scholar]
- 29.Sussman LK. Herbal medicine in Mauritius. J Ethnopharmacol. 1980;2:259–278. doi: 10.1016/s0378-8741(80)81005-1. [DOI] [PubMed] [Google Scholar]
- 30.Wang HX, Ng TB, Liu WK, Doi VEC, Chang ST. Isolation and characterization of two distinct lectins with anti-proliferative activity from the cultured mycelium of edible mushroom Tricholoma mongolicum. Inter J Peptide Protein Res. 1995;46:508–513. doi: 10.1111/j.1399-3011.1995.tb01606.x. [DOI] [PubMed] [Google Scholar]
- 31.Weyerstahl P, Marschall-Weyerstahl H, Christiansen C, Oguntimein BO, Adeoye AO. Volatile constituents of Eugenia uniflora leaf oil. Planta Med. 1988;54:546–549. doi: 10.1055/s-2006-962544. [DOI] [PubMed] [Google Scholar]